Analysts Set Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Target Price at $7.00
Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Get Free Report) has been given an average recommendation of “Hold” by the five ratings firms that are covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price target […]
Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Get Free Report) has been given an average recommendation of “Hold” by the five ratings firms that are covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price target […]
